Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A rationale for combined therapy with a calcium channel blocker and a statin: evaluation of basic and clinical evidence.

A rationale for combined therapy with a calcium channel blocker and a statin: evaluation of basic and clinical evidence. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec; 5(6):489-501.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.